Zhejiang Lepu Pharmaceutical Co Ltd, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PAZOPANIB HYDROCHLORIDE, with a corresponding US DMF Number 34146.
Remarkably, this DMF maintains an Active status since its submission on November 01, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 16, 2020, and payment made on September 13, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II